AiBiotics (CEO Ma Sang-bae, Ma Sang-hyuk), a startup specializing in biohealthcare, announced on the 11th that it has won the 17th Digital Innovation BT Award in 2022 organized by The Korea Times.
AI Biotics (CEOs Ma Sang-bae and Ma Sang-hyuk) is developing an ‘all-in-one RT-PCR device for point-of-care (POCT)’ that can test infectious diseases such as COVID-19 in real time. This dramatically improves analysis time and convenience by implementing the existing test system divided into nucleic acid extraction, amplification, and detection all in one device. Compared to some commercialized foreign-made rapid PCR test equipment for on-site diagnosis, it has excellent advantages for multiplex diagnosis, which can diagnose various diseases at once. Not many people realize that most of the reagents and equipment used in corona PCR tests are foreign-made. “In order for K-Bio to have international competitiveness, it is very important to develop and distribute domestic equipment,” said Ma Sang-bae, a former semiconductor engineer who is in charge of development. “The goal is to create a diagnostic device that is not just a diagnostic device but a tool that connects doctors and patients, and a diagnostic device that is close to life.”
Co-CEO Ma Sang-hyuk, a practicing physician, said, “We will create a diagnostic device that is essential for hospitals by directly participating in development.”